Home Overview Press Room Blog Publications For Students about us
Search

Personal genomics : Displaying 229-248 of 696


23andMe's Troubles: The Spat over Spit by Pete ShanksBiopolitical TimesDecember 5th, 2013First a warning letter from the FDA, then a class action lawsuit. What's next for Google-backed 23andMe, the only direct-to-consumer genetic testing company still in the game?
Die, Selfish Gene, Dieby David DobbsAeon MagazineDecember 3rd, 2013How vital, really, are actual changes in the genetic code? Do we even need DNA changes to adapt to new environments? Is the importance of the gene as the driver of evolution being overplayed?
The Failed Promise of 23andMeby Robert KlitzmanBloombergDecember 3rd, 2013The FDA should take stronger action to protect consumers from the risks associated with direct-to-consumer testing - especially overpromises about partial testing.
San Diego Woman Sues 23andMe Over DNA Testby Gary RobbinsUT San DiegoDecember 3rd, 2013A class-action lawsuit alleges that 23andMe knowingly misled consumers into thinking that its DNA test kits produce a reliable look at a person’s relative risk for hundreds of diseases and disorders.
Genetic Testing Should Adhere to Medical, Not Business, Ethics: FDA's Regulation of 23andMe Is a Welcome Move for Consumersby Karuna JaggarHuffington PostDecember 1st, 2013The truth is that we still understand very little about how our genes interact with our environment, and our individual choices, to impact our health.
23andMe Is Terrifying, But Not for the Reasons the FDA Thinksby Charles SeifeScientific AmericanNovember 27th, 2013As the FDA frets about the accuracy of 23andMe’s tests, it is missing their true function, and consequently the agency has no clue about the real dangers they pose.
Personalized Cancer Treatments Suffer Setbackby Erika Check HaydenNatureNovember 27th, 2013Much hope has been placed on therapies that play on the same mutations that make cells cancerous — but selecting the right drugs may be more complicated than expected.
FDA Bans 23andme Personal Genetic Tests[Quotes CGS's Marcy Darnovsky]BBC NewsNovember 26th, 2013The US Food and Drug Administration has imposed a ban on a company offering personal genetic screening to the general public.
FDA’s Warning to 23andMe is a Welcome Step toward Responsible Oversight, says Center for Genetics and Society [Press statement]November 26th, 2013The US Food and Drug Administration has ordered 23andMe to “immediately discontinue marketing” its direct-to-consumer genetic tests.
My Deadly Disease Was Just a Bugby Lukas Hartmannctrl+verlustNovember 25th, 2013An update to the author's 23andMe report informed him that he had the mutations to develop a life-threatening disease. Except that he didn't. This is his story.
F.D.A. Demands a Halt to a DNA Test Kit’s Marketingby Andrew PollackThe New York TimesNovember 25th, 2013The F.D.A. said that 23andMe has failed to provide adequate evidence that its Personal Genome Service provides accurate results.
Genetic Testing Leaves More Patients Living in Limboby Amy Dockser MarcusThe Wall Street JournalNovember 20th, 2013The expanding use of genetic testing is having an unforeseen consequence: More people are being told they have genes for potentially fatal diseases but don't show any symptoms.
Company Patenting Tech for Designing Babies[With CGS's Marcy Darnovsky]by John FowlerKTVUNovember 20th, 2013Biotechnology may give parents unprecedented choices. Fertility clinics already use pre-implantation genetic diagnosis to select traits for some in-vitro babies, but intentional manipulation might create ethical nightmares.
Genetic Testing Falls Flat in Large Patient Drug Trialsby Susan YoungMIT Technology ReviewNovember 19th, 2013Three large clinical trials show little benefit to analyzing the genes of patients to find the right dose of blood thinners.
In Defence of Privacyby Dr Stuart HogarthBioNewsNovember 18th, 2013Not everyone is convinced that the public disclosure policy of the Personal Genome Project is the best response to the difficulties of safeguarding genomic confidentiality.
Designing Childrenby Jonathan WebberGenomics Law ReportNovember 12th, 2013Some degree of mastery over the genetic future of the human species seems to be a possibility. For whom and for what does this technology exist?
Open-Access Genome Project Lands in UKby Ewen CallawayNatureNovember 7th, 2013The founder of the Personal Genome Project announced the launch of a UK edition, and a European franchise on the way for 2014.
Study Finds that Americans Want Doctors' Guidance on Genetic Test ResultsMedical XpressNovember 7th, 2013Like physician groups, members of the public are concerned about individuals interpreting the risks revealed by direct-to-consumer genetic testing without the help of a doctor.
NIH Seeks Comments on Plan to Share Genomic Databy Jessica CussinsBiopolitical TimesNovember 7th, 2013The National Institutes of Health is accepting public comments until November 20 on a draft Genomic Data Sharing Policy that promotes the wide-scale sharing of human and non-human genomic data.
The Frightening and Fraught Future of Genetic Testingby Michael WhitePacific StandardNovember 4th, 2013Will genetic testing become a routine part of our society's decision-making, influencing professional sports, the military, parole boards, political campaigns, and our own health, education, and career choices?
Displaying 229-248 of 696  
< Prev  Next >> 
« First Page Last Page » 
« Show Complete List » 


ESPAÑOL | PORTUGUÊS | Русский

home | overview | blog | publications| about us | donate | newsletter | press room | privacy policy

CGS • 1936 University Ave, Suite 350, Berkeley, CA 94704 • • (p) 1.510.665.7760 • (F) 1.510.665.8760